Resources | TAGRISSO

To simplify the application process, you will find the SGV cost coverage application form here that you can submit to the insurer or medical examiner.

German

French

LAURA cost coverage arguments

Supporting arguments for applying for cost coverage for

Download

German

French

Italian

Swiss Lung Cancer Treatment Map

All lung cancer therapies available in Switzerland at a glance. Use the map as an overview for your lung cancer therapy options, SL listings, ESMO guidelines recommended and further information.

Interactive Treatment Map

Helpful materials for your patients

Please enter the number of brochures that you would like to receive in each language, and enter your contact data so that we can send the documents to you.

TAGRISSO® Therapy Brochure

An information brochure for patients for whom TAGRISSO® was prescribed. This brochure contains practical hints and tips about the targeted therapy with TAGRISSO®, how to take the medication correctly, what side effects can occur, and what patients should look out for. A therapy diary is included to support patients and treating physicians in the treatment with TAGRISSO®. It enables recording of the personal treatment course in which the patient can keep sequential notes about his condition and potential side effects.

German

French

Italian

English

First name*

Surname*

Hospital/Practice*

E-mail address*

Street and house number*

Postal code*

City*

Yes, I would like to receive materials from AstraZeneca, or AstraZeneca sales partners by e-mail (e.g. congresses, presentations from speakers, studies or patient brochures). I am aware that I can withdraw my consent at any time at https://www.astrazenecapersonaldataretention.com/. More information on data protection can be found here.

DISCLAIMER
I agree that my data and usage statistics are stored electronically. The personal data is used to contact you by e-mail. The usage profiles are used for quality assurance and for individual analysis of usage behaviour, as described in the privacy policy. The usage behaviour includes information about when you have opened an e-mail from us or when you have clicked on a certain link in the e-mail. I am aware that I can revoke this consent at any time without justification (e.g. with an AstraZeneca sales representative or via the e-mail received).

Helpful links

You are now leaving the TAGRISSO website of AstraZeneca Switzerland

You are now leaving the TAGRISSO website of AstraZeneca Switzerland and thus our area of responsibility. The linked pages possess their own terms of use and are possibly subject to other legislation and standards.